Crohn Disease Clinical Trials in Palo Alto, California
3 recruitingPalo Alto, California
Showing 1–3 of 3 trials
Recruiting
Phase 1
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 2Phase 3
Precise Infliximab Exposure and Pharmacodynamic Control
Crohn Disease
Children's Hospital Medical Center, Cincinnati180 enrolled11 locationsNCT05660746
Recruiting
Not Applicable
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Crohn DiseaseUlcerative Colitis
University of California, San Diego250 enrolled22 locationsNCT05230173